Valuation: Galenica AG

Capitalization 4.12B 5.3B 4.5B 3.89B 7.25B 500B 7.31B 48.85B 19.04B 240B 19.87B 19.45B 829B P/E ratio 2026 *
22.8x
P/E ratio 2027 * 19.9x
Enterprise value 4.97B 6.4B 5.44B 4.69B 8.76B 604B 8.83B 59B 23B 290B 24B 23.5B 1,002B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.09x
Free-Float
99.39%
Yield 2026 *
3.07%
Yield 2027 * 3.23%
1 day-0.30%
1 week-0.24%
Current month-1.14%
1 month-9.21%
3 months-18.11%
6 months-5.18%
Current year-15.76%
1 week 81.7
Extreme 81.7
84.1
1 month 81.7
Extreme 81.7
91.6
Current year 81.7
Extreme 81.7
103
1 year 81.7
Extreme 81.7
103
3 years 65.1
Extreme 65.1
103
5 years 60.55
Extreme 60.55
103
10 years 41.8
Extreme 41.8
103
Manager TitleAgeSince
Chief Executive Officer 59 31/03/2020
Director of Finance/CFO - 31/12/2024
Chief Tech/Sci/R&D Officer 54 31/12/2021
Director TitleAgeSince
Director/Board Member 61 31/12/2017
Chairman 68 02/05/2023
Director/Board Member 49 31/12/2019
Change 5d. change 1-year change 3-years change Capi.($)
-1.00%-0.24%-3.18%+7.37% 5.3B
-2.47%-9.57%+6.15%+86.61% 88.48B
-0.88%-5.94%+23.90%+115.60% 43.01B
-0.35%+0.35%-7.19%+305.71% 23.74B
-0.12%-0.27%-14.21%-19.58% 8.58B
-0.35%-0.12%-6.05%-23.86% 8.42B
0.00%-1.60%-1.02%-31.87% 7.35B
-0.74%+2.96%+42.78%+16.04% 6.48B
-0.20%-2.32%-2.70%-13.61% 3.7B
-0.72%-2.32%+11.19%+32.08% 3.62B
Average -0.54%-1.77%+4.97%+47.45% 19.87B
Weighted average by Cap. -1.38%-5.43%+7.61%+98.14%

Financials

2026 *2027 *
Net sales 4.36B 5.6B 4.76B 4.11B 7.67B 529B 7.74B 51.68B 20.14B 254B 21.02B 20.58B 878B 4.52B 5.81B 4.94B 4.27B 7.96B 549B 8.03B 53.6B 20.9B 264B 21.8B 21.35B 910B
Net income 180M 232M 197M 170M 317M 21.89B 320M 2.14B 833M 10.51B 869M 851M 36.29B 223M 287M 244M 211M 393M 27.14B 397M 2.65B 1.03B 13.04B 1.08B 1.06B 45.01B
Net Debt 856M 1.1B 935M 808M 1.51B 104B 1.52B 10.16B 3.96B 49.95B 4.13B 4.04B 172B 790M 1.02B 863M 746M 1.39B 95.99B 1.4B 9.37B 3.65B 46.11B 3.81B 3.73B 159B
Logo Galenica AG
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Employees
6,577
Date Price Change Volume
11/05/26 81.75 CHF -1.09% 17,076
08/05/26 82.65 CHF -0.42% 95,884
07/05/26 83.00 CHF +0.97% 108,325
06/05/26 82.20 CHF +0.18% 112,596
05/05/26 82.05 CHF -0.55% 83,461
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
82.65CHF
Average target price
88.00CHF
Spread / Average Target
+6.47%

Annual profits - Rate of surprise